sur Onco-Innovations Limited (CVE:ONCO)
Onco-Innovations to Lead Key Oncology Forum on Precision Medicine
Onco-Innovations Limited's subsidiary, Inka Health Corp., will chair a vital roundtable as part of Colorectal Cancer Canada's "Catalysts: Innovating for Tomorrow Series." This event, set to occur in the fall, will focus on data innovation and digital trust in oncology. This initiative underscores Onco-Innovations' growing role in shaping crucial discussions around cancer care.
The roundtable, led by Inka Health Co-Founder Dr. Paul Arora, will address topics such as artificial intelligence integration and secure data sharing. It aims to explore the use of emerging data sources to advance precision medicine globally. This reflects the pressing need for healthcare systems to adopt new technologies responsibly.
Expert participation includes Dr. Steve Jones, Dr. Winson Cheung, and Inka Health Co-Founder Alind Gupta. Their insights are expected to strengthen Onco-Innovations' leadership through substantial partnerships and influence in AI-enabled healthcare.
R. H.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Onco-Innovations Limited